Possis Medical (POSS) Reports Q2 EPS of $0.03
More News related to POSS
- S&P Announces Changes to U.S. Indices (AINV for MGI, AIRM for POSS)
- Possis Medical (POSS) Reports Q2 EPS of $0.03
- Unusual 11 Mid-Day Movers 2/11: NYNY, HYC, POSS, IDMI Higher; NURO, PNM, LCAV Lower
- Pre-Open Movers 2/11: Hypercom (HYC), Possis Medical (POSS) Higher on Takeover Offers; Builders FirstSource (BLDR) Down on Guidance
- Bayer To Acquire Possis Medical (POSS) for $19.50/Share
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
Possis Medical Inc. (Nasdaq: POSS) reports Q2 EPS of $0.03, versus the consensus of $0.04. Revenues came in at $20.6 million, versus the consensus of $19.05 million.
Possis Medical, Inc. develops, manufactures, and distributes medical devices, primarily targeting catheter-based therapies for the treatment of vascular disorders.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
